Kyntra Bio (KYNB) vs Optimi Health (OPTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kyntra Bio is the larger company by market cap ($24.1 million vs $23.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KYNB | OPTH |
|---|---|---|
| Share price | $5.96 | $4.09 |
| Market cap | $24.13M | $23.39M |
| 1-day change | -1.32% | 0.00% |
| YTD return | -32.12% | — |
| 1-year return | -47.72% | — |
| 5-year return | -97.84% | — |
| EPS (TTM) | $-7.64 | $-1.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.65 | $6.40 |
| 52-week low | $5.62 | $4.00 |
| Distance from 52-week high | -48.84% | -36.17% |
| Average volume | 18.32K | 45.35K |
| Shares outstanding | 4.05M | 5.73M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
KYNB vs OPTH FAQ
Which is bigger, Kyntra Bio or Optimi Health?
Kyntra Bio (KYNB) is larger, with a market capitalization of $24.13M compared with $23.39M for Optimi Health (OPTH).
Are Kyntra Bio and Optimi Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.